Summary
In skin fibroblasts of patients presenting with galactosaemia, either from galactose 1-phosphate uridyltransferase or galactokinase deficiency, a deficit in extracellular glucose utilization was observed. This deficit was constant over 3 weeks of continuous cell growth in a medium containing 5.5 mmol/L glucose as the only hexose, and homologous serum. Levels of glucose utilization by deficient skin fibroblasts were stable at about 65–70% of the glucose utilization of control normal skin fibroblasts. Cell morphology was normal, and cell growth was subnormal during this period. However, the energy provision appeared sufficient for cellular needs since cell growth in this glucose medium was observed not to depend on the presence of extracellular glutamine. In contrast, glutamine was required for growth of galactosaemic fibroblasts cultured in medium containing 5.5 mmol/L galactose. If expressed in many cell types, this impaired glucose uptake would be expected seriously to damage highly glucose-dependent tissues such as the central nervous system. This might be of relevance to the persistent neurological damage observed in many galactosaemic patients in spite of their compliance with an early strict galactose-free diet.
Similar content being viewed by others
References
Dobbie JA, Holton JB, Clamp JR (1990) Defective galactosylation of proteins in cultured fibroblasts from galactosaemic patients.Ann Clin Biochem 27: 274–275.
Friedman TB, Yarkin RJ, Merril CR (1975) Galactose and glucose metabolism in galactokinase deficient, galactose-1-P-uridyltransferase deficient and normal human fibroblasts.J Cell Physiol 85: 569–578.
Germinario RJ, Lakshmi TM, Thirion JP (1989) Kinetic characteristics and regulation of hexose transport in a galactokinase-negative chinese hamster fibroblast cell line: a good model for studies on sugar transport in cultured mammalian cells.J Cell Physiol 138: 300–304.
Granett SE, Kozak LP, McIntyre JP, Wells WW (1972) Studies on cerebral energy metabolism during the course of galactose neurotoxicity in chicks.J Neurochem 19: 1659–1670.
Guerroui S, Moatti N, Soni T, Lemonnier A (1988) CO2 production from hexoses in both normal and pathological conditions.Med Sci Res 16: 355–357.
Haier RJ, Siegel BV Jr, MacLachlan A, Soderling E, Lottenberg S, Buchsbaum MS (1992) Regional glucose metabolic changes after learning a complex visuospatial/motor task: a positron emission tomographic study.Brain Res 570: 134–143.
Human Gene Mapping (1990)Cytogenet Cell Genet 10.5.
Kadhom N, Brivet M, Baptista J, Gautier M, Lemonnier A (1989) Coopération métabolique dans des cocultures de fibroblastes issus de patients atteints d'anomalies différentes du métabolisme du galactose.CR Acad Sci Paris 308: 453–458.
Krooth RS, Weinberg AN (1961) Studies on cell lines developed from the tissues of patients with galactosemia.J Exp Med 113: 1155–1171.
Lemonnier F, Gautier M, Wolfrom C, Lemonnier A (1980) Some metabolic differences between human skin and aponeurosis fibroblasts in culture.J Cell Physiol 104: 415–423.
Levy HL, Hammersen G (1978) Newborn screening for galactosaemia and other galactose metabolic defects.J Pediatr 92: 871–877.
Malone JI, Wells H, Segal S (1972) Decreased uptake of glucose by brain of the galactose toxic chick.Brain Res 43: 700–704.
Mayes JS, Miller LR (1973) The metabolism of galactose by galactosemic fibroblastsin vitro.Biochem Biophys Acta 313: 9–16.
Ng WG, Xu YK, Kaufman FR, Donnell GN (1989) Deficit of uridine diphosphate galactose in galactosemia.J Inher Metab Dis 12: 257–266.
Petry K, Greinix HT, Nudelman E et al (1991) Characterization of a novel biochemical abnormality in galactosaemia: deficiency of glycolipids containing galactose orN-acetylgalactosamine and accumulation of precursors in brain and lymphocytes.Biochem Med Metab Biol 46: 93–104.
Pourci ML, Mangeot M, Lemonnier A (1985) Origin of the galactose-1-phosphate present in erythrocytes and fibroblasts of treated galactosemic patients.IRCS Med Sci 13: 1232–1233.
Pourci ML, Mangeot M, Soni T, Lemonnier A (1990) Culture of galactosaemic fibroblasts in the presence of galactose: effect of inosine.J Inher Metab Dis 13: 819–828.
Reichardt JKV, Woo SLC (1991) Molecular basis of galactosemia: Mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase.Proc Natl Acad Sci USA 88: 2633–2637.
Reichardt JKV, Packman S, Woo SLC (1991) Molecular characterization of two galactosaemia mutations: correlation of mutations with highly conserved domains in galactose-1-phosphate uridyltransferase.Am J Hum Genet 49: 860–867.
Russell JD, DeMars R (1967) UDP-Glucose: αd-galactose-1-phosphate uridylyltransferase activity in cultured human fibroblasts.Biochem Genet 1: 11–24.
Segal S, Rutman JY, Frimpter GW (1979) Galactokinase deficiency and mental retardation.J Pediatr 95: 750–752.
Sell Stern E, Krooth RS (1974) Studies on the regulation of the three enzymes of the Leloir pathway in cultured mammalian cells.J Cell Physiol 86: 91–104.
Shin-Buehring YS, Beier T, Tan A, Osang M, Schaub J (1977) The activity of galactose-1-phosphate uridyltransferase and galactokinase in human fetal organs.Pediatr Res 11: 1003–1009.
Soni T, Wolfrom C, Guerroui S et al (1991) Respective effects of glucose and glutamine on the glutamine synthetase activity of human skin fibroblasts.Mol Cell Biochem 102: 149–154.
Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases.J Inher Metab Dis 13: 802–818.
Wolfrom C, Kadhom N, Poggi J, Moatti N, Gautier M (1989) Glutamine dependency of human skin fibroblasts: modulation by hexoses.Exp Cell Res 183: 303–318.
Zielke HR, Ozand PT, Tildon JT, Sevdalian DA, Cornblath M (1978) Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts.J Cell Physiol 95: 41–48.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolfrom, C., Raynaud, N., Kadhom, N. et al. Impaired hexose uptake by diploid skin fibroblasts from galactosaemic patients. Connection with cell growth and amino acid metabolism, and possible bearing on late-onset clinical symptoms. J Inherit Metab Dis 16, 78–90 (1993). https://doi.org/10.1007/BF00711319
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711319